Significance of Resveratrol in Clinical Management of Chronic Diseases. (Q38618547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

3 references

18 November 2020

8 April 2021

25 June 2021

Significance of Resveratrol in Clinical Management of Chronic Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

18 November 2020

1 reference

8 April 2021

1 reference

25 June 2021

Awais Wahab

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Kuo Gao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Caixia Jia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Feilong Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Guihua Tian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Ghulam Murtaza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Jianxin Chen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

language of work or name

English

0 references

publication date

18 August 2017

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

18 November 2020

8 April 2021

25 June 2021

4 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

18 November 2020

8 April 2021

25 June 2021

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

27 March 2020

copyright license

3 references

18 November 2020

8 April 2021

25 June 2021

0 references

Tissue Distribution of trans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes.

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol and Ophthalmic Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol supplementation: Where are we now and where should we go?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Drug interaction potential of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Trans-resveratrol alters mammary promoter hypermethylation in women at increased risk for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Short-term supplementation with a specific combination of dietary polyphenols increases energy expenditure and alters substrate metabolism in overweight subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol enhances TNF-α production in human monocytes upon bacterial stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol for primary prevention of atherosclerosis: clinical trial evidence for improved gene expression in vascular endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Optimization of trans-Resveratrol bioavailability for human therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Central administration of resveratrol improves diet-induced diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol and cancer: focus on in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol plays dual roles in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Consumption of a Western-style diet during pregnancy impairs offspring islet vascularization in a Japanese macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol in cardiovascular disease: what is known from current research?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Inflammatory mechanisms in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol as a therapeutic agent for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Neuroprotective effect of resveratrol on rotenone-treated C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Of mice and men: the benefits of caloric restriction, exercise, and mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol-procyanidin blend: nutraceutical and antiaging efficacy evaluated in a placebocontrolled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Health benefits of physical activity: the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effects of Resveratrol Supplementation and Exercise Training on Exercise Performance in Middle-Aged Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Effect of resveratrol and quercetin supplementation on redox status and inflammation after exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

A healthier approach to clinical trials evaluating resveratrol for primary prevention of age‐related diseases in healthy populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Finding a target for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

The molecular targets of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Challenges of translating basic research into therapeutics: resveratrol as an example

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Administration of resveratrol: What formulation solutions to bioavailability limitations?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Enhancing the bioavailability of resveratrol by combining it with piperine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES22081329

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

21 January 2018

1 reference

12 December 2020

Photoprotective activity of resveratrol analogues

1 reference

12 December 2020

Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids

1 reference

12 December 2020

Resveratrol confers endothelial protection in insulin-dependent diabetes mellitus: editorial to: "Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits" by

1 reference

12 December 2020

Resveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high-intensity interval training in humans

1 reference

12 December 2020

Recent data do not provide evidence that resveratrol causes 'mainly negative' or 'adverse' effects on exercise training in humans

1 reference

12 December 2020

Food and therapeutic product interactions - a therapeutic perspective.

1 reference

12 December 2020

Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.

1 reference

12 December 2020

Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer

1 reference

12 December 2020

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness

1 reference

12 December 2020

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration

1 reference

12 December 2020

Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats

1 reference

12 December 2020

Obesity: the 'huge' problem in cardiovascular diseases

1 reference

12 December 2020

Effect of the intake of resveratrol, resveratrol phosphate, and catechin-rich grape seed extract on markers of oxidative stress and gene expression in adult obese subjects

1 reference

12 December 2020

10.3390/MOLECULES22081329

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28820474%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference